Capstone Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $784K | Buy |
6,047
+324
| +6% | +$42K | 0.02% | 681 |
|
|
2017
Q1 | $775K | Buy |
5,723
+316
| +6% | +$42.8K | 0.02% | 676 |
|
|
2016
Q4 | $776K | Sell |
5,407
-1,060
| -16% | -$152K | 0.02% | 678 |
|
|
2016
Q3 | $764K | Sell |
6,467
-445
| -6% | -$52.6K | 0.02% | 705 |
|
|
2016
Q2 | $732K | Buy |
6,912
+922
| +15% | +$97.6K | 0.02% | 705 |
|
|
2016
Q1 | $667K | Buy |
5,990
+541
| +10% | +$60.2K | 0.02% | 746 |
|
|
2015
Q4 | $853K | Sell |
5,449
-148
| -3% | -$23.2K | 0.02% | 651 |
|
|
2015
Q3 | $735K | Buy |
5,597
+601
| +12% | +$78.9K | 0.02% | 682 |
|
|
2015
Q2 | $869K | Sell |
4,996
-489
| -9% | -$85.1K | 0.03% | 640 |
|
|
2015
Q1 | $946K | Buy |
5,485
+262
| +5% | +$45.2K | 0.03% | 692 |
|
|
2014
Q4 | $676K | Sell |
5,223
-410
| -7% | -$53.1K | 0.02% | 853 |
|
|
2014
Q3 | $725K | Buy |
5,633
+110
| +2% | +$14.2K | 0.02% | 770 |
|
|
2014
Q2 | $489K | Sell |
5,523
-367
| -6% | -$32.5K | 0.02% | 1084 |
|
|
2014
Q1 | $554K | Sell |
5,890
-200
| -3% | -$18.8K | 0.02% | 987 |
|
|
2013
Q4 | $689K | Sell |
6,090
-3,637
| -37% | -$411K | 0.02% | 866 |
|
|
2013
Q3 | $767K | Buy |
9,727
+160
| +2% | +$12.6K | 0.02% | 967 |
|
|
2013
Q2 | $630K | Buy |
+9,567
| New | +$630K | 0.02% | 1026 |
|